IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30

$3.48−0.17 (-4.79%)

Close on Nov 13, 2026Market cap $25.64MP/E –Yield –

Immutep ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Immutep has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMMP.

Revenue growth133.9% · median 89.5%

Net margin-328.1% · median -612.9%

Advertisement
300 × 250

See a number that looks wrong?